高级检索
当前位置: 首页 > 详情页

The tumor suppressor role of miR-4782-3p in hepatocellular carcinoma

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Hepatobiliary and Gastrointestinal Surgery, Sichuan Provincial Cancer Hospital,Chengdu, Sichuan 610041, P.R. China
出处:
ISSN:

关键词: miR-4782-3p cell growth apoptosis patient survival USP14

摘要:
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortalities in China. Although advances have been made in treatments, the prognosis of HCC patients has not improved significantly. MicroRNAs (miRNA) play important roles in all stage of the progress of HCC. miR-4782-3p takes part in the pathogenesis of non-small cell lung cancer (NSCLC). However, the role of miR-4782-3p in HCC remains unknown. In the present study, we found that miR-4782-3p had low expression in HCC tissues. The low expression of miR-4782-3p indicated shorter survival of HCC patients. Moreover, the low expression of miR-4782-3p promoted HCC cells growth and inhibited cell apoptosis. We confirmed that USP14 was targeted by miR-4782-3p in HCC cells.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2016]版:
Q3 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Department of Hepatobiliary and Gastrointestinal Surgery, Sichuan Provincial Cancer Hospital,Chengdu, Sichuan 610041, P.R. China
通讯作者:
通讯机构: [1]Department of Hepatobiliary and Gastrointestinal Surgery, Sichuan Provincial Cancer Hospital,Chengdu, Sichuan 610041, P.R. China [*1]Department of Hepatobiliary and Gastrointestinal Surgery, Sichuan Provincial Cancer Hospital, 55 People's South Road 4th Section, Chengdu, Sichuan 610041, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:46676 今日访问量:3 总访问量:3332 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号